NeuroPace Inc Quarterly Operating Income (Loss) in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NeuroPace Inc quarterly/annual Operating Income (Loss) history and growth rate from Q1 2020 to Q3 2024.
  • NeuroPace Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.24M, a 28.7% increase year-over-year.
  • NeuroPace Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$23.1M, a 27.9% increase year-over-year.
  • NeuroPace Inc annual Operating Income (Loss) for 2023 was -$27.2M, a 33.4% increase from 2022.
  • NeuroPace Inc annual Operating Income (Loss) for 2022 was -$40.8M, a 71.9% decline from 2021.
  • NeuroPace Inc annual Operating Income (Loss) for 2021 was -$23.7M, a 81.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$23.1M -$4.24M +$1.71M +28.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$24.8M -$6.23M +$1.62M +20.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$26.4M -$7.55M +$774K +9.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$27.2M -$5.05M +$4.81M +48.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$32M -$5.95M +$4.25M +41.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$36.2M -$7.85M +$3.12M +28.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$39.4M -$8.32M +$1.44M +14.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$40.8M -$9.86M -$844K -9.36% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$40M -$10.2M -$3.96M -63.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$36M -$11M -$6.37M -138% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$29.6M -$9.76M -$5.89M -152% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$23.7M -$9.02M -$6.03M -202% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 -$17.7M -$6.24M -$5.08M -435% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$12.6M -$4.61M -$1.16M -33.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$11.5M -$3.87M +$1.58M +29% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$13.1M -$2.98M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$1.17M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.45M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$5.46M Jan 1, 2020 Mar 31, 2020 10-Q 2021-06-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.